vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Commercial Vehicle Group, Inc. (CVGI). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $154.8M, roughly 1.3× Commercial Vehicle Group, Inc.). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -5.2%). Commercial Vehicle Group, Inc. produced more free cash flow last quarter ($8.7M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -10.8%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...
AXSM vs CVGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $154.8M |
| Net Profit | $-28.6M | — |
| Gross Margin | — | 9.7% |
| Operating Margin | -13.8% | -1.2% |
| Net Margin | -14.6% | — |
| Revenue YoY | 65.0% | -5.2% |
| Net Profit YoY | 61.9% | — |
| EPS (diluted) | $-0.55 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $154.8M | ||
| Q3 25 | $171.0M | $152.5M | ||
| Q2 25 | $150.0M | $172.0M | ||
| Q1 25 | $121.5M | $169.8M | ||
| Q4 24 | $118.8M | $163.3M | ||
| Q3 24 | $104.8M | $171.8M | ||
| Q2 24 | $87.2M | $193.7M | ||
| Q1 24 | $75.0M | $194.6M |
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-47.2M | $-7.1M | ||
| Q2 25 | $-48.0M | $-4.8M | ||
| Q1 25 | $-59.4M | $-4.3M | ||
| Q4 24 | $-74.9M | — | ||
| Q3 24 | $-64.6M | $9.5M | ||
| Q2 24 | $-79.3M | $-1.6M | ||
| Q1 24 | $-68.4M | $2.9M |
| Q4 25 | — | 9.7% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | — | 10.5% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | — | 9.6% | ||
| Q2 24 | — | 10.6% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | -13.8% | -1.2% | ||
| Q3 25 | -27.0% | -0.7% | ||
| Q2 25 | -24.5% | 0.5% | ||
| Q1 25 | -46.9% | 0.8% | ||
| Q4 24 | -61.1% | -3.2% | ||
| Q3 24 | -59.8% | -0.6% | ||
| Q2 24 | -89.5% | 0.5% | ||
| Q1 24 | -89.7% | 2.3% |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -27.6% | -4.6% | ||
| Q2 25 | -32.0% | -2.8% | ||
| Q1 25 | -48.9% | -2.5% | ||
| Q4 24 | -63.1% | — | ||
| Q3 24 | -61.7% | 5.5% | ||
| Q2 24 | -91.0% | -0.8% | ||
| Q1 24 | -91.1% | 1.5% |
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | — | ||
| Q2 25 | $-0.97 | — | ||
| Q1 25 | $-1.22 | — | ||
| Q4 24 | $-1.54 | — | ||
| Q3 24 | $-1.34 | — | ||
| Q2 24 | $-1.67 | $-0.05 | ||
| Q1 24 | $-1.44 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | — |
| Total DebtLower is stronger | — | $104.9M |
| Stockholders' EquityBook value | $88.3M | $133.4M |
| Total Assets | $689.8M | $391.7M |
| Debt / EquityLower = less leverage | — | 0.79× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | — | ||
| Q2 25 | $303.0M | — | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $315.4M | — | ||
| Q3 24 | $327.3M | — | ||
| Q2 24 | $315.7M | — | ||
| Q1 24 | $331.4M | — |
| Q4 25 | — | $104.9M | ||
| Q3 25 | — | $108.2M | ||
| Q2 25 | — | $118.2M | ||
| Q1 25 | — | $117.4M | ||
| Q4 24 | — | $135.5M | ||
| Q3 24 | — | $128.8M | ||
| Q2 24 | — | $142.0M | ||
| Q1 24 | — | $155.7M |
| Q4 25 | $88.3M | $133.4M | ||
| Q3 25 | $73.7M | $136.5M | ||
| Q2 25 | $73.1M | $142.6M | ||
| Q1 25 | $53.2M | $136.7M | ||
| Q4 24 | $57.0M | $135.6M | ||
| Q3 24 | $92.9M | $179.3M | ||
| Q2 24 | $102.9M | $169.6M | ||
| Q1 24 | $144.0M | $175.5M |
| Q4 25 | $689.8M | $391.7M | ||
| Q3 25 | $669.3M | $400.3M | ||
| Q2 25 | $639.8M | $429.8M | ||
| Q1 25 | $596.7M | $419.8M | ||
| Q4 24 | $568.5M | $424.6M | ||
| Q3 24 | $561.5M | $495.3M | ||
| Q2 24 | $548.2M | $503.2M | ||
| Q1 24 | $545.7M | $509.2M |
| Q4 25 | — | 0.79× | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 1.00× | ||
| Q3 24 | — | 0.72× | ||
| Q2 24 | — | 0.84× | ||
| Q1 24 | — | 0.89× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $12.3M |
| Free Cash FlowOCF − Capex | $-18.7M | $8.7M |
| FCF MarginFCF / Revenue | -9.6% | 5.6% |
| Capex IntensityCapex / Revenue | 0.0% | 2.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $34.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $12.3M | ||
| Q3 25 | $1.0M | $-1.7M | ||
| Q2 25 | $-32.4M | $18.9M | ||
| Q1 25 | $-43.4M | $15.2M | ||
| Q4 24 | $-26.2M | $-26.6M | ||
| Q3 24 | $-18.6M | $-17.1M | ||
| Q2 24 | $-30.1M | $12.6M | ||
| Q1 24 | $-53.5M | $-2.4M |
| Q4 25 | $-18.7M | $8.7M | ||
| Q3 25 | $988.0K | $-3.5M | ||
| Q2 25 | $-32.4M | $17.4M | ||
| Q1 25 | $-43.7M | $11.4M | ||
| Q4 24 | $-26.2M | $-30.6M | ||
| Q3 24 | $-18.7M | $-20.3M | ||
| Q2 24 | $-30.2M | $6.4M | ||
| Q1 24 | $-53.6M | $-7.4M |
| Q4 25 | -9.6% | 5.6% | ||
| Q3 25 | 0.6% | -2.3% | ||
| Q2 25 | -21.6% | 10.1% | ||
| Q1 25 | -36.0% | 6.7% | ||
| Q4 24 | -22.1% | -18.7% | ||
| Q3 24 | -17.9% | -11.8% | ||
| Q2 24 | -34.6% | 3.3% | ||
| Q1 24 | -71.4% | -3.8% |
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 1.2% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.3% | 2.2% | ||
| Q4 24 | 0.0% | 2.4% | ||
| Q3 24 | 0.1% | 1.9% | ||
| Q2 24 | 0.1% | 3.2% | ||
| Q1 24 | 0.1% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.79× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |
